Idexx Laboratories (IDXX) EBIT Margin (2009 - 2026)
Idexx Laboratories (IDXX) posted EBIT Margin of 34.98% for Q2 2026, up 1.36 percentage points from 33.62% a year earlier and up 3.20 percentage points from the prior quarter.
Powered by 
Analysis
Idexx Laboratories (IDXX) EBIT Margin (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT Margin at Idexx Laboratories was 32.03%, up 0.95 percentage points year-over-year; for FY2025, it came in at 31.60%, up 2.65 percentage points from FY2024.
- Annual EBIT Margin shows a five-year change of +5.94 percentage points (FY2020 to FY2025).
- In prior years, Idexx Laboratories' EBIT Margin was 28.95% in FY2024 (-1.02 pp), 29.97% in FY2023 (+3.28 pp), 26.69% in FY2022 (-2.30 pp) and 28.99% in FY2021 (+3.33 pp).
- The Q2 2026 figure stands as the highest quarterly EBIT Margin in data going back to Q2 2009.
- On a year-over-year basis, EBIT Margin has increased in each of the last eight quarters, with an average year-over-year change of +1.65 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q2 2023, with a gain of 10.58 percentage points; the weakest was Q2 2022, with a drop of 10.57 percentage points.
- According to Business Quant data, EBIT Margin for the three prior quarters was 31.78% (Q1 2026), 28.94% (Q4 2025) and 32.11% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 21.81% |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | 28.37% |
| 10 | Idexx Laboratories | 40.86 Bn | 40.07 Bn | 779.09 Mn | 34.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.98% |
| Mar 31, 2026 | 31.78% |
| Dec 31, 2025 | 28.94% |
| Sep 30, 2025 | 32.11% |
| Jun 30, 2025 | 33.62% |
| Mar 31, 2025 | 31.70% |
| Dec 31, 2024 | 27.42% |
| Sep 30, 2024 | 31.15% |
| Jun 30, 2024 | 26.29% |
| Mar 31, 2024 | 31.01% |
| Dec 31, 2023 | 27.21% |
| Sep 30, 2023 | 30.07% |
| Jun 30, 2023 | 31.38% |
| Mar 31, 2023 | 31.15% |
| Dec 31, 2022 | 27.34% |
| Sep 30, 2022 | 29.09% |
| Jun 30, 2022 | 20.81% |
| Mar 31, 2022 | 29.69% |
| Dec 31, 2021 | 24.86% |
| Sep 30, 2021 | 27.88% |
API Access
Idexx Laboratories EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=IDXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "IDXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=IDXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();